Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.
2.

Molecular aspects of regulation of collagen gene expression in fibrosis.

Bhogal RK, Stoica CM, McGaha TL, Bona CA.

J Clin Immunol. 2005 Nov;25(6):592-603. Review.

PMID:
16380822
3.

Recombinant immunoglobulin-based epitope delivery: a novel class of autoimmune regulators.

Phillips WJ, Smith DJ, Bona CA, Bot A, Zaghouani H.

Int Rev Immunol. 2005 Sep-Dec;24(5-6):501-17. Review.

PMID:
16318992
4.

B cells: no longer bystanders in liver fibrosis.

Bhogal RK, Bona CA.

J Clin Invest. 2005 Nov;115(11):2962-5.

5.
6.

Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.

Preda I, McEvoy RC, Lin M, Bona CA, Rapaport R, Brumeanu TD, Casares S.

Eur J Immunol. 2005 Sep;35(9):2762-75.

7.

Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts.

McGaha TL, Le M, Kodera T, Stoica C, Zhu J, Paul WE, Bona CA.

Arthritis Rheum. 2003 Aug;48(8):2275-84.

8.

Role of profibrogenic cytokines secreted by T cells in fibrotic processes in scleroderma.

McGaha TL, Bona CA.

Autoimmun Rev. 2002 May;1(3):174-81. Review.

PMID:
12849012
9.

Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism.

McGaha TL, Kodera T, Spiera H, Stan AC, Pines M, Bona CA.

Arthritis Rheum. 2002 Oct;46(10):2748-61.

10.

Association of 5'-untranslated region of the Fibrillin-1 gene with Japanese scleroderma.

Kodera T, Tan FK, Sasaki T, Arnett FC, Bona CA.

Gene. 2002 Sep 4;297(1-2):61-7.

PMID:
12384286
11.
12.

Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-beta production by fibroblasts.

Kodera T, McGaha TL, Phelps R, Paul WE, Bona CA.

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3800-5. Epub 2002 Mar 12.

13.

Modulation of CD4 T cell function by soluble MHC II-peptide chimeras.

Casares S, Bona CA, Brumeanu TD.

Int Rev Immunol. 2001 Oct;20(5):547-73. Review.

PMID:
11890612
14.

T-cell tolerance and autoimmune diabetes.

Brumeanu TD, Bona CA, Casares S.

Int Rev Immunol. 2001;20(2):301-31. Review.

PMID:
11878772
15.

Genetic defects in tight skin mice developing a scleroderma-like syndrome.

Bona CA.

Curr Dir Autoimmun. 1999;1:194-207. Review. No abstract available.

PMID:
11791442
16.

Anti-fibrillin-1 autoantibodies in systemic sclerosis are GM and KM allotype-restricted.

Pandey JP, Page GP, Silver RM, LeRoy EC, Bona CA.

Exp Clin Immunogenet. 2001;18(3):123-9.

PMID:
11549841
17.

Enzymatically mediated engineering of multivalent MHC class II-peptide chimeras.

Casares S, Bona CA, Brumeanu TD.

Protein Eng. 2001 Mar;14(3):195-200.

PMID:
11342717
18.

Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populations.

Tan FK, Wang N, Kuwana M, Chakraborty R, Bona CA, Milewicz DM, Arnett FC.

Arthritis Rheum. 2001 Apr;44(4):893-901.

19.

CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes.

Stan AC, Casares S, Brumeanu TD, Klinman DM, Bona CA.

Eur J Immunol. 2001 Jan;31(1):301-10.

20.

Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II--peptide chimera.

Casares S, Stan AC, Bona CA, Brumeanu TD.

Nat Biotechnol. 2001 Feb;19(2):142-7.

PMID:
11175728
21.

Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles.

Tan FK, Arnett FC, Reveille JD, Ahn C, Antohi S, Sasaki T, Nishioka K, Bona CA.

Arthritis Rheum. 2000 Nov;43(11):2464-71.

22.

A targeted mutation in the IL-4Ralpha gene protects mice against autoimmune diabetes.

Radu DL, Noben-Trauth N, Hu-Li J, Paul WE, Bona CA.

Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12700-4.

23.

Fine specificity of anti-fibrillin-1 autoantibodies in primary pulmonary hypertension syndrome.

Morse JH, Antohi S, Kasturi K, Saito S, Fotino M, Humbert M, Simonneau G, Basst RJ, Bona CA.

Scand J Immunol. 2000 Jun;51(6):607-11.

24.

Escape from self-tolerance leads to neonatal insulin-dependent diabetes mellitus.

Radu DL, Brumeanu TD, McEvoy RC, Bona CA, Casares S.

Autoimmunity. 1999;30(4):199-207.

PMID:
10524496
25.
26.

Characterization of mutated protein encoded by partially duplicated fibrillin-1 gene in tight skin (TSK) mice.

Saito S, Nishimura H, Brumeanu TD, Casares S, Stan AC, Honjo T, Bona CA.

Mol Immunol. 1999 Feb;36(3):169-76.

PMID:
10403482
27.

Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases.

Tan FK, Arnett FC, Antohi S, Saito S, Mirarchi A, Spiera H, Sasaki T, Shoichi O, Takeuchi K, Pandey JP, Silver RM, LeRoy C, Postlethwaite AE, Bona CA.

J Immunol. 1999 Jul 15;163(2):1066-72.

28.

Expression of granulocyte colony-stimulating factor in recurrent glial tumors is inversely correlated with tumor progression.

Stan AC, Walter GF, Welte K, Schneider B, Bona CA, Pietsch T.

J Neuroimmunol. 1999 Feb 1;94(1-2):66-73.

PMID:
10376937
29.
30.

Spontaneous occurrence of anti-fibrillin-1 autoantibodies in tight-skin mice.

Murai C, Saito S, Kasturi KN, Bona CA.

Autoimmunity. 1998;28(3):151-5.

PMID:
9867127
31.
32.

Effect of targeted mutation in collagen V alpha 2 gene on development of cutaneous hyperplasia in tight skin mice.

Phelps RG, Murai C, Saito S, Hatakeyama A, Andrikopoulos K, Kasturi KN, Bona CA.

Mol Med. 1998 May;4(5):356-60.

33.

Idiotype vaccines: forgotten but not gone.

Bona CA.

Nat Med. 1998 Jun;4(6):668-9. No abstract available.

PMID:
9623971
34.

Foreign peptides expressed in engineered chimeric self molecules.

Casares S, Bot A, Brumeanu TD, Bona CA.

Biotechnol Genet Eng Rev. 1998;15:159-98. Review. No abstract available.

PMID:
9573608
35.

Towards development of T-cell vaccines.

Bona CA, Casares S, Brumeanu TD.

Immunol Today. 1998 Mar;19(3):126-33. Review.

PMID:
9540272
36.
37.

B-cell deficiency does not abrogate development of cutaneous hyperplasia in mice inheriting the defective fibrillin-1 gene.

Kasturi KN, Hatakeyama A, Murai C, Gordon R, Phelps RG, Bona CA.

J Autoimmun. 1997 Dec;10(6):505-17.

PMID:
9451590
38.
39.

Presentation of a viral peptide assembled on the carbohydrate moieties of immunoglobulin does not require processing.

Brumeanu TD, Casares S, Dehazya P, Bot S, Bona CA.

Eur J Immunol. 1997 Sep;27(9):2408-16.

PMID:
9341787
40.

Structure of the mutant fibrillin-1 gene in the tight skin (TSK) mouse.

Bona CA, Murai C, Casares S, Kasturi K, Nishimura H, Honjo T, Matsuda F.

DNA Res. 1997 Aug 31;4(4):267-71.

PMID:
9405934
41.

Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenza virus.

Brumeanu TD, Casares S, Bot A, Bot S, Bona CA.

J Virol. 1997 Jul;71(7):5473-80.

42.
43.

Immunogenicity of viral epitopes expressed on genetically and enzymatically engineered immunoglobulins.

Bona CA, Bot A, Brumeanu TD.

Chem Immunol. 1997;65:179-206. Review. No abstract available.

PMID:
9018878
44.

V lambda-light chain genes reconstitute immune responses to defined carbohydrate antigens or haptens by utilizing different VH genes.

Bot A, Nangpal A, Pricop L, Bogen B, Kaushik A, Bona CA.

Mol Immunol. 1996 Dec;33(17-18):1359-68.

PMID:
9171895
45.

Functional characterization of monoclonal antibodies specific to growth hormone receptor.

Wang BS, Lumanglas AL, Bona CA, Moran TM.

Mol Immunol. 1996 Oct;33(15):1197-202.

PMID:
9070668
46.

Internal image concept revisited.

Bona CA.

Proc Soc Exp Biol Med. 1996 Oct;213(1):32-42. Review.

PMID:
8820821
47.

Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice.

Bot A, Reichlin A, Isobe H, Bot S, Schulman J, Yokoyama WM, Bona CA.

J Virol. 1996 Aug;70(8):5668-72.

48.

Immunopotency of a viral peptide assembled on the carbohydrate moieties of self immunoglobulins.

Brumeanu TD, Casares S, Harris PE, Dehazya P, Wolf I, von Boehmer H, Bona CA.

Nat Biotechnol. 1996 Jun;14(6):722-5.

PMID:
9630978
49.

Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes.

Brumeanu TD, Bot A, Bona CA, Dehazya P, Wolf I, Zaghouani H.

Immunotechnology. 1996 Jun;2(2):85-95.

PMID:
9373317
50.

Supplemental Content

Support Center